John Overdeck’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-38,000
Closed -$650K 3414
2018
Q3
$650K Buy
+38,000
New +$653K ﹤0.01% 2277
2018
Q2
Sell
-89,000
Closed -$1.56M 3573
2018
Q1
$1.56M Buy
89,000
+61,000
+218% +$1.27M 0.01% 1705
2017
Q4
$644K Sell
28,000
-101,800
-78% -$2.11M ﹤0.01% 2264
2017
Q3
$2.72M Buy
129,800
+53,800
+71% +$991K 0.01% 1146
2017
Q2
$1.53M Buy
76,000
+22,400
+42% +$488K 0.01% 1603
2017
Q1
$1.3M Buy
+53,600
New +$1.45M ﹤0.01% 1742
2016
Q4
Sell
-88,700
Closed -$1.98M 3444
2016
Q3
$1.98M Buy
88,700
+72,700
+454% +$1.46M 0.01% 1460
2016
Q2
$341K Sell
16,000
-8,000
-33% -$151K ﹤0.01% 2481
2016
Q1
$423K Buy
24,000
+6,000
+33% +$89.5K ﹤0.01% 2166
2015
Q4
$271K Buy
18,000
+2,000
+13% +$30.8K ﹤0.01% 2303
2015
Q3
$210K Sell
16,000
-33,000
-67% -$523K ﹤0.01% 1962
2015
Q2
$922K Buy
49,000
+8,000
+20% +$166K ﹤0.01% 1704
2015
Q1
$770K Buy
+41,000
New +$703K ﹤0.01% 1739

Other funds holding PTEN

John Overdeck's PTEN Position: Q2 2026 in Review

John Overdeck reduced its Patterson-UTI (PTEN) stake by 28% in Q2 2026, selling an estimated $11M and leaving 2,595,426 shares worth $23.8M. The position accounts for 0.02% of the portfolio, ranked #942.

John Overdeck first reported a position in PTEN in Q1 2014 and has held it in 36 quarters since. The position peaked at $64.5M in Q1 2014. 435 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • John Overdeck held 2,595,426 shares of Patterson-UTI worth $23.8M as of Q2 2026.
  • John Overdeck sold 988,828 Patterson-UTI shares in Q2 2026, an estimated $11M.
  • Patterson-UTI made up 0.02% of John Overdeck's portfolio in Q2 2026, its #942 holding.
  • John Overdeck first reported a position in Patterson-UTI in Q1 2014 and has held it in 36 quarters since.
  • John Overdeck's Patterson-UTI position peaked at $64.5M in Q1 2014.
  • 435 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.